The North America cancer tissue diagnostics market is expected to reach US$ 1,587.38 Mn in 2027 from US$ 923.79 Mn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.
The growth of the market is driven by the factors such as, growing cancer prevalence in North American region and new product launches & FDA approvals. However, the market is likely to slower down its growth due to the lack of reimbursement policies for cancer diagnosis in the region.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00006459
Frequent FDA approvals and product launches fuel the growth of the market for cancer tissue diagnostics. Most of the major market players are involved in the manufacturing wide range of cancer diagnostics products that offer maximum advantages and early diagnosis. For instance, in June 2019, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its PD-L1 IHC 22C3 pharmDx assay. The assay is approved to aim in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA (pembrolizumab), anti-PD-1 therapy manufactured by Merck. Furthermore, In March 2018, Agilent Technologies Inc. launched a new color for immunohistochemistry: HRP Magenta for Dako Omnis. The latest staining characteristics of the chromogen will help it for the assessment of skin and lung tissue. Thus, the constant developments in technology in diagnostics along with, FDA approvals accelerate the market growth during the forecast period.
US is expected to lead the market in the North America region owing to increasing prevalence of cancer, improved diagnosis and treatment of the condition along with the advancements made by market players. Moreover, the country has several hospitals, super specialty hospitals which offers diagnostic and treatment services for the cardiovascular diseases. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-cancer-tissue-diagnostics-market
𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Abbott
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Danaher Corporation
Abcam plc
North America Cancer Tissue Diagnostics Market
The North America Cancer Tissue Diagnostics market is a rapidly evolving sector within the global healthcare industry. This market primarily involves the use of advanced diagnostic tools and techniques to detect and diagnose various forms of cancer in tissue samples. The rise in the prevalence of cancer, along with advancements in technology, is driving significant growth in the cancer tissue diagnostics market. In North America, particularly in the United States and Canada, there is a strong focus on improving diagnostic accuracy, expanding access to testing, and enhancing treatment outcomes for patients.
Market Overview
Cancer is one of the leading causes of death in North America. According to the American Cancer Society, an estimated 1.9 million new cancer cases are expected to be diagnosed in the United States in 2025, with nearly 600,000 deaths from the disease. This highlights the urgent need for effective and timely diagnostic tools that can accurately detect cancer at various stages of progression. Tissue diagnostics, including techniques like immunohistochemistry (IHC), in situ hybridization (ISH), and molecular diagnostics, play a pivotal role in identifying the presence of cancer and providing information that can guide treatment decisions.
Moreover, the U.S. boasts an extensive network of hospitals and super-specialty cancer centers equipped with state-of-the-art diagnostic technologies. Institutions such as the Memorial Sloan Kettering Cancer Center, Johns Hopkins Medicine, and MD Anderson Cancer Center provide cutting-edge diagnostic and treatment services, enabling timely and accurate cancer diagnoses. These institutions play a key role in integrating new diagnostic products, such as FDA-approved assays and IHC staining technologies, into their clinical workflows.
Market Growth Prospects in the U.S.
As the U.S. healthcare landscape continues to evolve, the integration of advanced diagnostic techniques into routine clinical practice is expected to accelerate. In particular, the introduction of personalized and precision medicine—where cancer treatments are tailored to the individual genetic makeup of the patient—is gaining traction. Tissue diagnostics are at the heart of personalized medicine, as they provide valuable information about the genetic and molecular characteristics of the cancer, which in turn guides therapeutic decision-making. This shift toward personalized treatment is expected to drive significant growth in the cancer tissue diagnostics market over the forecast period.
The U.S. government also continues to invest in cancer research and early detection initiatives. Programs such as the Cancer Moonshot Initiative and funding through the National Cancer Institute (NCI) aim to accelerate cancer research and the development of new diagnostic technologies. These initiatives not only support scientific advancements but also ensure that the latest technologies are accessible to healthcare providers across the country, facilitating the widespread adoption of innovative cancer tissue diagnostic solutions.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
The list Of Companies-
3D and 4D Technology Market- https://www.openpr.com/news/3921417/3d-and-4d-technology-market-segments-opportunities-regional
Last Mile Delivery Market- https://www.openpr.com/news/3921138/last-mile-delivery-market-global-analysis-size-share
Europe Barbeque Grill Market- https://www.openpr.com/news/3921830/europe-barbeque-grill-market-segments-opportunities
